[ Inside the business ]

CTVA stock analysis

CTVA · Corteva, Inc.

Agricultural production-crops. Shrinking 6%.

Watch: growth that has stopped speeding up.

The future, in 7 questions

01 What's priced in?Not available

Needs today's sales, share count and price.

02 Is the wave rising?Gene editing · 0.8×
'20'21'22'23'24'25107
#17 of 20 mentioning it
03 Will customers keep buying?Sales −6%, slowing
No customer over 10%
Backlog $158M · under 0.1× salesPrepaid $440MSales −6%, slowing
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Not enough data
Before running costs: 40% → 47%
06 Can it fund itself?Burning cash
05 yrs10+ yrs
Shares −2.2%/yrDebt $3.5B
07 What could break it?2 to watch
  • Growth slowing
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth slowing.

Sales growth +11%, −1%, then −6% vs. a year ago. New filings show insiders buying.

What could go wrong

Steadier than most.

It has moved 0.7× the market. In the 2020 covid crash it fell 18% while the market fell 19%. Debt is covered by cash. Guarantees: $120M.

Speculative check

Not classified.

Not Self-funding because of: loss in the latest quarter. Cash runway: Invests beyond its cash flow.

What they sell

Not broken out.

The filings don't split revenue by product in structured data.

Where each dollar goes

Not available.

Cost lines aren't reported in a comparable form.

Its market

No projection.

The government's 10-year projections don't cover its industry code.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Growth.

It earns cash, invests heavily, and still raises money to grow.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 56¢ of each $1 of profit.

Competitive advantage

Not measurable.

Returns on capital can't be computed from its filings (common for banks and insurers).

Future bets

9% on research.

$1.5B a year on R&D. $576M on equipment and buildings.

All figures from Corteva, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.